H. Lundbeck A/S Braces For 2012-14 Profit Slide

COPENHAGEN, Nov 3 (Reuters) - Drugmaker Lundbeck (LUN.CO) on Wednesday spelled out for the first time the likely cost of generic competition to its key drug, warning profit could slide by a third in 2012-2014.